Angiogenesis Completed Phase 1 / 2 Trials for Erythropoietin (DB00016)

IndicationStatusPhase
DBCOND0036757 (Angiogenesis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03162588Multiple Burrhole Therapy With Erythropoietin for Unstable MoyamoyaTreatment